NPI: 1356720023 · NORTH LAS VEGAS, NV 89030 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/27/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/27/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,631 | $405K |
| 2019 | 47,420 | $642K |
| 2020 | 49,721 | $720K |
| 2021 | 58,428 | $774K |
| 2022 | 50,523 | $787K |
| 2023 | 28,309 | $834K |
| 2024 | 11,475 | $759K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 88,809 | 4,026 | $4.91M |
| J1756 | Injection, iron sucrose, 1 mg | 24,663 | 2,948 | $3K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 78,282 | 2,339 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 41,323 | 2,029 | $1K |
| A4657 | Syringe, with or without needle, each | 8,490 | 2,607 | $918.16 |
| 90661 | 13 | 12 | $36.85 | |
| G0008 | Administration of influenza virus vaccine | 235 | 106 | $32.37 |
| 90674 | 127 | 59 | $25.17 | |
| 85048 | 5,723 | 2,098 | $0.00 | |
| 83540 | 3,163 | 1,108 | $0.00 | |
| 83970 | 4,935 | 1,819 | $0.00 | |
| 82108 | 1,911 | 716 | $0.00 | |
| 85041 | 5,825 | 2,138 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 2,279 | 476 | $0.00 |
| 83550 | 2,026 | 895 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,771 | 476 | $0.00 |
| 82728 | 2,605 | 938 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 898 | 333 | $0.00 |
| 82746 | 429 | 167 | $0.00 |